What Makes Novo Nordisk A/S (NVO) a Promising and Profitable Investment in The Long Term?
Vltava Fund, an investment management company, recently released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Novo Nordisk A S (NVO)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 11,000,916 | $759,283,294 | -8% | 0.3% |
| 2. | Renaissance Technologies Jim Simons | 4,936,796 | $340,737,660 | -28% | 0.45% |
| 3. | 3,876,500 | $267,556,030 | +11% | 0.05% | |
| 4. | 2,935,700 | $202,622,014 | +26% | 0.04% | |
| 5. | Markel Gayner Asset Management Tom Gayner | 2,258,588 | $155,887,745 | +6% | 1.32% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,642,498 | $146,644,237 | 0.78% | |
| 2. | 426,700 | $23,677,583 | 2.36% | |
| 3. | 299,144 | $16,599,501 | 6.26% | |
| 4. | 272,869 | $15,141,517 | 0.29% | |
| 5. | 165,219 | $11,403,415 | 3.47% |
News See All
Morgan Stanley Downgrades Novo Nordisk A/S (NVO) from Equal-Weight to Underweight
Morgan Stanley downgraded Novo Nordisk A/S (NYSE:NVO) from Equal-Weight to Underweight on September 29, 2025, and dropped its price target from $53.20 to $42.
20 Best Stocks to Buy and Hold for a Lifetime
As employment growth slows and inflation rises, the EY US Economic Outlook, September 2025, projects that real GDP will grow by 1.7% this year and 1.4% in 2026, indicating a slowdown in U.S.
Novo Nordisk A/S (NVO) Attracts Park Avenue Securities Investment
Novo Nordisk A/S (NYSE:NVO) is among the best safe stocks to buy now.
12 Best Safe Stocks to Buy Now
One thing that holds people back from investing is the risk associated with stocks. This is why it’s important to identify stocks that are stable yet forward-looking.
Berenberg Upgrades Novo Nordisk (NVO) Amid Renewed Growth Outlook
Novo Nordisk A/S (NYSE:NVO) is one of the best beginner stocks to buy, according to analysts.
12 Best Beginner Stocks to Buy According to Analysts
Stronger-than-expected corporate profits and the prospect of the US Federal Reserve cutting interest rates are the catalysts likely to push equity markets higher.
Novo Nordisk A/S (NVO): A Bull Case Theory
We came across a bullish thesis on Novo Nordisk A/S on Summit Stocks’s Substack by Summit Stocks. In this article, we will summarize the bulls’ thesis on NVO.
Jim Cramer Discusses Novo Nordisk A/S (NVO) And CVS
Novo Nordisk A/S (NYSE:NVO) revealed last week that it would cut 9,000 jobs as part of a cost-cutting push through which it expects to save $1.3 billion.
8 Stocks on Jim Cramer's Radar
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed OpenAI's spending and billionaires.
Hedge Fund Resource Center Billionaire Hedge Funds
